Homocysteine levels are associated with hippocampus volume in type 2 diabetic patients

Eur J Clin Invest 2011; 41 (7): 751–758

[1]  Santhosh K. P. Kumar,et al.  Neurotoxicity associated with dual actions of homocysteine at the N-methyl-D-aspartate receptor. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[2]  N. Nagelkerke,et al.  A note on a general definition of the coefficient of determination , 1991 .

[3]  R. Turner,et al.  Homeostasis model assessment: insulin resistance and β-cell function from fasting plasma glucose and insulin concentrations in man , 1985, Diabetologia.

[4]  C. R. Park,et al.  Cognitive effects of insulin in the central nervous system , 2001, Neuroscience & Biobehavioral Reviews.

[5]  A. Dominiczak,et al.  2007 ESH-ESC Practice Guidelines for the Management of Arterial Hypertension: ESH-ESC Task Force on the Management of Arterial Hypertension. , 2007, Journal of hypertension.

[6]  G. Reaven Role of Insulin Resistance in Human Disease , 1988, Diabetes.

[7]  J. Ashburner,et al.  Multimodal Image Coregistration and Partitioning—A Unified Framework , 1997, NeuroImage.

[8]  Karl J. Friston,et al.  Voxel-Based Morphometry—The Methods , 2000, NeuroImage.

[9]  T. Maruyama,et al.  Effects of short-term folic acid and/or riboflavin supplementation on serum folate and plasma total homocysteine concentrations in young Japanese male subjects , 2006, European Journal of Clinical Nutrition.

[10]  P. Behn,et al.  Hepatocyte nuclear factor 1alpha coding mutations are an uncommon contributor to early-onset type 2 diabetes in Ashkenazi Jews. , 1998, Diabetes.

[11]  D. Bennett,et al.  From Healthy Aging to Early Alzheimer's Disease: In Vivo Detection of Entorhinal Cortex Atrophy , 2000, Annals of the New York Academy of Sciences.

[12]  E. Giltay,et al.  Insulin resistance is associated with elevated plasma total homocysteine levels in healthy, non-obese subjects. , 1998, Atherosclerosis.

[13]  D. Fuchs,et al.  Hyperhomocysteinemia in dementia , 2000, Neurobiology of Aging.

[14]  S. Doré,et al.  Distribution and levels of [125I]IGF-I, [125I]IGF-II and [125I]insulin receptor binding sites in the hippocampus of aged memory-unimpaired and -impaired rats , 1997, Neuroscience.

[15]  C. Culmsee,et al.  Homocysteine Elicits a DNA Damage Response in Neurons That Promotes Apoptosis and Hypersensitivity to Excitotoxicity , 2000, The Journal of Neuroscience.

[16]  H. Iso,et al.  Effects of serum B vitamins on elevated plasma homocysteine levels associated with the mutation of methylenetetrahydrofolate reductase gene in Japanese. , 2002, Atherosclerosis.

[17]  B. McEwen,et al.  Glucose transporter expression in the central nervous system: relationship to synaptic function. , 2004, European journal of pharmacology.

[18]  D. Amaral,et al.  Hippocampal abnormalities in amnesic patients revealed by high-resolution magnetic resonance imaging , 1989, Nature.

[19]  L. Fink,et al.  Effects of a high-fat-sucrose diet on enzymes in homocysteine metabolism in the rat. , 2000, Metabolism: clinical and experimental.

[20]  S. Folstein,et al.  "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician. , 1975, Journal of psychiatric research.

[21]  L. Reagan,et al.  Insulin signaling effects on memory and mood. , 2007, Current opinion in pharmacology.

[22]  A. Dominiczak,et al.  2007 Guidelines for the Management of Arterial Hypertension: The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC) , 2007, European heart journal.

[23]  Kevin M Bradley,et al.  Minimal hippocampal width relates to plasma homocysteine in community-dwelling older people. , 2002, Age and ageing.

[24]  P A Wolf,et al.  Primary prevention of ischemic stroke: A statement for healthcare professionals from the Stroke Council of the American Heart Association. , 2001, Circulation.

[25]  V. Sánchez-Margalet,et al.  Homocysteine thiolactone inhibits insulin-stimulated DNA and protein synthesis: possible role of mitogen-activated protein kinase (MAPK), glycogen synthase kinase-3 (GSK-3) and p70 S6K phosphorylation. , 2005, Journal of molecular endocrinology.

[26]  P. J. Koudstaal,et al.  Type 2 diabetes and atrophy of medial temporal lobe structures on brain MRI , 2003, Diabetologia.

[27]  J. Lindsay,et al.  Vascular dementia : incidence and risk factors in the Canadian study of health and aging. , 2000, Stroke.

[28]  E. Mariani,et al.  Homocysteine and cognitive function in healthy elderly community dwellers in Italy. , 2003, The American journal of clinical nutrition.

[29]  A. Folsom,et al.  Multiple Metabolic Syndrome Is Associated With Lower Heart Rate Variability: The Atherosclerosis Risk in Communities Study , 1998, Diabetes Care.

[30]  S. Baxendale,et al.  Amnesia in temporal lobectomy patients: Historical perspective and review , 1998, Seizure.

[31]  A Hofman,et al.  Homocysteine and brain atrophy on MRI of non-demented elderly. , 2003, Brain : a journal of neurology.

[32]  Nobuoki Eshima,et al.  Abdominal visceral fat accumulation is associated with hippocampus volume in non-dementia patients with type 2 diabetes mellitus , 2010, NeuroImage.

[33]  V. Sánchez-Margalet,et al.  Homocysteine thiolactone inhibits insulin signaling, and glutathione has a protective effect. , 2001, Journal of molecular endocrinology.

[34]  G. Reaven Banting lecture 1988. Role of insulin resistance in human disease. , 1988, Diabetes.

[35]  L. Launer,et al.  Type 2 diabetes, APOE gene, and the risk for dementia and related pathologies: The Honolulu-Asia Aging Study. , 2002, Diabetes.

[36]  P. Raskin,et al.  A double blind comparison of the effects of amlodipine and enalapril on insulin sensitivity in hypertensive patients. , 1999, American journal of hypertension.

[37]  Takashi Asada,et al.  Voxel-based morphometry to discriminate early Alzheimer's disease from controls , 2005, Neuroscience Letters.

[38]  M. Mattson,et al.  Folic Acid Deficiency and Homocysteine Impair DNA Repair in Hippocampal Neurons and Sensitize Them to Amyloid Toxicity in Experimental Models of Alzheimer's Disease , 2002, The Journal of Neuroscience.

[39]  M. Brosnan,et al.  Effects of streptozotocin-induced diabetes and of insulin treatment on homocysteine metabolism in the rat. , 1998, Diabetes.

[40]  T. Shoji,et al.  Impact of insulin resistance and nephropathy on homocysteine in type 2 diabetes. , 2001, Diabetes care.

[41]  C. Jack,et al.  Prediction of AD with MRI-based hippocampal volume in mild cognitive impairment , 1999, Neurology.

[42]  C. Jack,et al.  Rate of medial temporal lobe atrophy in typical aging and Alzheimer's disease , 1998, Neurology.

[43]  G. Fulcher,et al.  The relationship among homocysteine, creatinine clearance, and albuminuria in patients with type 2 diabetes. , 2001, Diabetes care.

[44]  D. Alkon,et al.  Brain Insulin Receptors and Spatial Memory , 1999, The Journal of Biological Chemistry.

[45]  A. Rudich,et al.  Oxidative Stress Disrupts Insulin-induced Cellular Redistribution of Insulin Receptor Substrate-1 and Phosphatidylinositol 3-Kinase in 3T3-L1 Adipocytes , 1999, The Journal of Biological Chemistry.

[46]  S. Woods,et al.  Intracerebroventricular insulin enhances memory in a passive-avoidance task , 2000, Physiology & Behavior.